Abstract
“Nutrigenomics” refers to the ability of nutrients to alter gene expression. Insulin secreting β-cells exhibit genomic and molecular changes that enhance their function when acutely exposed to physiological concentrations of glucose and fatty acids. However, chronic exposure, such as occurs in the hyperlipidemic, hyperglycemic state of obesity/ prediabetes can exert deleterious effects on β-cell function through alteration of gene expression. The genomic underpinnings of so-called glucolipotoxicity on the β-cell and its relationship to development of type 2 diabetes will be discussed in this review article. For example, free fatty acids influence β-cell gene expression by direct interaction with transcription factors such as peroxisome proliferator-activated receptors. Glucose responsive genes include the insulin gene as well as genes involved in β-cell survival and other functions. In addition, obesity is now recognized as a condition of chronic, low-level inflammation. The adipose tissue secretes multiple circulating hormones termed adipokines, and the relationship between these and the β-cell has been termed adipotoxicity. The influence of adipokines on regulation of insulin secretion and β-cell survival will be reviewed.
Keywords: Insulin, β-cell, glucolipotoxicity, adipotoxicity, nutrigenomics
Current Genomics
Title: Nutrigenomics, β-Cell Function and Type 2 Diabetes
Volume: 8 Issue: 1
Author(s): R. Nino-Fong, T. M. Collins and C. B. Chan
Affiliation:
Keywords: Insulin, β-cell, glucolipotoxicity, adipotoxicity, nutrigenomics
Abstract: “Nutrigenomics” refers to the ability of nutrients to alter gene expression. Insulin secreting β-cells exhibit genomic and molecular changes that enhance their function when acutely exposed to physiological concentrations of glucose and fatty acids. However, chronic exposure, such as occurs in the hyperlipidemic, hyperglycemic state of obesity/ prediabetes can exert deleterious effects on β-cell function through alteration of gene expression. The genomic underpinnings of so-called glucolipotoxicity on the β-cell and its relationship to development of type 2 diabetes will be discussed in this review article. For example, free fatty acids influence β-cell gene expression by direct interaction with transcription factors such as peroxisome proliferator-activated receptors. Glucose responsive genes include the insulin gene as well as genes involved in β-cell survival and other functions. In addition, obesity is now recognized as a condition of chronic, low-level inflammation. The adipose tissue secretes multiple circulating hormones termed adipokines, and the relationship between these and the β-cell has been termed adipotoxicity. The influence of adipokines on regulation of insulin secretion and β-cell survival will be reviewed.
Export Options
About this article
Cite this article as:
Nino-Fong R., Collins M. T. and Chan B. C., Nutrigenomics, β-Cell Function and Type 2 Diabetes, Current Genomics 2007; 8 (1) . https://dx.doi.org/10.2174/138920207780076947
DOI https://dx.doi.org/10.2174/138920207780076947 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Smoking and Congenital Heart Disease: The Epidemiological and Biological Link
Current Pharmaceutical Design Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration
Current Vascular Pharmacology Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science The State of the Problem of Achieving Extremely Low LDL Levels
Current Pharmaceutical Design Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study
Reviews on Recent Clinical Trials Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Near Infrared Spectroscopy in Healthy Preterm and Term Newborns: Correlation with Gestational Age and Standard Monitoring Parameters
Current Neurovascular Research Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Biology of Circulating Nucleic Acids and Possible Roles in Diagnosis and Treatment in Diabetes and Cancer
Infectious Disorders - Drug Targets Cocoa Polyphenols: Evidence from Epidemiological Studies
Current Pharmaceutical Design Advanced Glycation Endproducts and Diabetes. Beyond Vascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome
Current Metabolomics Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Pharmacological Treatment of Hypertension in Pregnancy
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Metformin
Current Drug Safety Use of Metformin and Survival of Diabetic Women with Breast Cancer
Current Drug Safety Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?
Current Drug Targets Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research